Real World Study of a Adalimumab Biosimilar (Geleli) in Rheumatoid Arthritis

NCT05240859 · clinicaltrials.gov ↗

UNKNOWN

Status

1600

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Geleli

Sponsor

Peking University People's Hospital